C M Bidwell & Associates LTD Myriad Genetics Inc Transaction History

C M Bidwell & Associates LTD

  • $162 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$27.23 - $45.56 $120,492 - $201,603
-4,425 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$37.57 - $50.34 $61,802 - $82,809
1,645 Added 59.17%
4,425 $204,000
Q2 2018

Aug 13, 2018
BUY
$27.75 - $40.17 $77,145 - $111,672
2,780 New
2,780 $104,000

Others Institutions Holding MYGN

# of Institutions
253
Shares Held
90.5M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.11B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track C M Bidwell & Associates LTD Portfolio

Follow C M Bidwell & Associates LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

News

Stay updated on C M Bidwell & Associates LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email